Free Trial
NYSEARCA:KBNDIV

KranesShares Bloomberg Barclays China Bond Inclusi (KBNDIV) Price, Holdings, & News

About KranesShares Bloomberg Barclays China Bond Inclusi (NYSEARCA:KBNDIV)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
Assets Under Management
$25.00
Dividend Yield
N/A
Net Expense Ratio
0.00%
Aggregate Rating
N/A

ETF Overview

KranesShares Bloomberg Barclays China Bond Inclusi Expenses

TypeKBNDIVNYSEARCA ETFsAll ETFs
Management Fee0.00%0.52%0.53%
Other Expenses0.00%0.56%0.51%
Total Expense0.00%0.73%0.71%
Fee Waiver0.00%-0.65%-0.54%
Net Expense0.00%0.58%0.60%
Receive KBNDIV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for KranesShares Bloomberg Barclays China Bond Inclusi and its competitors with MarketBeat's FREE daily newsletter.

KBNDIV ETF News Headlines

Barclays US Savings Review
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
China 10-Year Bond Yield
Barclays Bank CD Rates March 2023
See More Headlines

KBNDIV ETF - Frequently Asked Questions

Shares of KBNDIV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Fund Details

Issuer
Fund Name
KranesShares Bloomberg Barclays China Bond Inclusi
Tax Classification
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:KBNDIV
Inception Date
1/1/2100
Fund Manager
N/A
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Benchmark
N/A
Category
Focus
Development Level
Region
Number of Holdings
0

Fund Statistics

Assets Under Management
$25.00
Average Daily Volume
$0.00
Discount/Premium
0.00%

Administrator, Advisor and Custodian

Administrator
N/A
Advisor
N/A
Custodian
N/A
Distributor
N/A
Transfer Agent
N/A
Trustee
N/A
Lead Market Maker
N/A

Miscellaneous

Beta
N/A
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NYSEARCA:KBNDIV) was last updated on 5/30/2025 by MarketBeat.com Staff
From Our Partners